Does subclinical hypothyroidism affect cardiac pump performance?
Evidence from a magnetic resonance imaging study
Andrea Ripoli, PhD*,
Alessandro Pingitore, MD, PhD*,*,
Brunella Favilli, MSc*,
Antonio Bottoni, MD*,
Stefano Turchi, BSc*,
Nael F. Osman, PhD ,
Daniele De Marchi, RT*,
Massimo Lombardi, MD*,
Antonio L'Abbate, MD and
Giorgio Iervasi, MD*
* Institute of Clinical Physiology, C.N.R., Pisa, Italy
Johns Hopkins University, Baltimore, Maryland
Scuola Superiore S. Anna and Institute of Clinical Physiology, C.N.R., Pisa, Italy

View larger version (32K):
[in a new window]
|
Figure 1 Scatterplots showing the relationship between thyroid-stimulating hormone (TSH) and end-diastolic volume (EDV), stroke volume (SV), cardiac index (CI), systemic vascular resistance (SVR), and apical greatest systolic lengthening (E1) and apical greatest systolic shortening (E2). Open circles = subclinical hypothyroidism (SHT) patients before thyroid replacement therapy; filled circles = SHT patients after thyroid replacement therapy; open triangles = control group.
|
|

View larger version (20K):
[in a new window]
|
Figure 2 Histograms showing the values of the tagging parameters in the control group and subclinical hypothyroidism (SHT) group before treatment. Alfa = angular deviation of greatest systolic lengthening (E1); E2 = greatest systolic shortening.
|
|

View larger version (21K):
[in a new window]
|
Figure 3 Histograms showing the values of the tagging parameters in the subclinical hypothyroidism (SHT) patients before and after treatment. Alfa = angular deviation of greatest systolic lengthening (E1); E2 = greatest systolic shortening.
|
|
|